HCA Healthcare Inc (HCA) SVP Deborah M. Reiner Sells 723 Shares

HCA Healthcare Inc (NYSE:HCA) SVP Deborah M. Reiner sold 723 shares of the firm’s stock in a transaction dated Monday, November 5th. The stock was sold at an average price of $135.06, for a total value of $97,648.38. Following the sale, the senior vice president now directly owns 6,184 shares of the company’s stock, valued at $835,211.04. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

NYSE HCA opened at $135.36 on Tuesday. The stock has a market capitalization of $46.52 billion, a price-to-earnings ratio of 20.54, a PEG ratio of 1.18 and a beta of 0.48. HCA Healthcare Inc has a 1-year low of $74.26 and a 1-year high of $141.11.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, October 30th. The company reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.23. The company had revenue of $11.45 billion during the quarter, compared to the consensus estimate of $11.29 billion. HCA Healthcare had a negative return on equity of 73.71% and a net margin of 6.82%. HCA Healthcare’s revenue was up 7.1% compared to the same quarter last year. During the same period in the previous year, the company posted $1.13 EPS. Equities research analysts anticipate that HCA Healthcare Inc will post 9.33 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 28th. Shareholders of record on Monday, December 3rd will be given a $0.35 dividend. This represents a $1.40 annualized dividend and a yield of 1.03%. The ex-dividend date of this dividend is Friday, November 30th. HCA Healthcare’s dividend payout ratio is currently 21.24%.

HCA has been the subject of a number of recent analyst reports. Credit Suisse Group raised their price objective on HCA Healthcare from $122.00 to $143.00 and gave the stock an “outperform” rating in a research report on Friday, July 27th. SunTrust Banks reissued a “buy” rating and set a $125.00 price objective on shares of HCA Healthcare in a research report on Friday, July 20th. Citigroup raised their price objective on HCA Healthcare from $136.00 to $156.00 and gave the stock a “buy” rating in a research report on Thursday, October 11th. ValuEngine raised HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Wednesday, July 18th. Finally, Royal Bank of Canada raised their price objective on HCA Healthcare to $150.00 and gave the stock an “outperform” rating in a research report on Monday, September 10th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $141.26.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. FMR LLC grew its position in HCA Healthcare by 54.9% in the 2nd quarter. FMR LLC now owns 5,488,273 shares of the company’s stock valued at $563,097,000 after acquiring an additional 1,944,961 shares in the last quarter. Millennium Management LLC boosted its stake in shares of HCA Healthcare by 32.3% in the 2nd quarter. Millennium Management LLC now owns 1,698,536 shares of the company’s stock valued at $174,270,000 after buying an additional 414,877 shares during the period. Highstreet Asset Management Inc. purchased a new position in shares of HCA Healthcare in the 2nd quarter valued at about $707,000. Stephens Inc. AR purchased a new position in shares of HCA Healthcare in the 2nd quarter valued at about $1,393,000. Finally, Tavio Capital LLC boosted its stake in shares of HCA Healthcare by 51.9% in the 2nd quarter. Tavio Capital LLC now owns 197,318 shares of the company’s stock valued at $20,245,000 after buying an additional 67,385 shares during the period. 70.84% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: This report was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.dispatchtribunal.com/2018/11/06/hca-healthcare-inc-hca-svp-deborah-m-reiner-sells-723-shares.html.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Further Reading: Diversification For Individual Investors

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply